Non-steroidal anti-inflammatory drugs (NSAIDs) and ovulation: Lessons from morphology

Histology and Histopathology

Volumn 21, Issue 4-6, 2006, Pages 541-556

  Gaytan M ^a   Morales, C ^a   Bellido, C ^a   Sanchez Criado J E ^a   Gaytan F ^a  

^a Universidad de Cordoba   (Spain)

Author keywords

Follicle rupture; Indomethacin; Ovulation; Rat

Indexed keywords

ANTIGESTAGEN; CHORIONIC GONADOTROPIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; GONADOTROPIN; INDOMETACIN; ISOPROTEIN; LUTEINIZING HORMONE; MATRIX METALLOPROTEINASE; MIFEPRISTONE; NONSTEROID ANTIINFLAMMATORY AGENT; PROGESTERONE RECEPTOR; PROSTAGLANDIN; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; EXPERIMENTAL MODEL; FEMALE; FEMALE INFERTILITY; FERTILIZATION; GENE TARGETING; HUMAN; IMMATURITY; MAMMAL; MORPHOLOGY; NIDATION; NONHUMAN; OVARY FOLLICLE; OVARY INSUFFICIENCY; OVULATION INDUCTION; OVULATION INHIBITION; PROGESTERONE SYNTHESIS; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; FEMALE; GONADOTROPINS; INDOMETHACIN; INFERTILITY, FEMALE; OVARIAN FOLLICLE; OVULATION; PROSTAGLANDINS; RATS;

MAMMALIA;

EID: 33645569868     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (98)

1. Akil M., Amos R.S. and Stewart P. (1996). Infertility may sometimes be associated with NSAID consumptiom. Br. J. Rheumatol. 35, 76-78.
2. Ando M., Kol S., Irahara M., Sirois J. and Hadáis E.Y. (1999). Non-steroidal anti-inflammatory drugs (NSAIDS) block the late, prostanoid-dependent/ceramide-independent component of ovarian IL-1 action: implications for the ovulatory process. Mol. Cell. Endocrinol. 25, 21-30.
3. Baek S.J., Wilson L.C., Lee C. and Eling T.E. (2002). Dual function of non-steroidal anti-inflammatory drugs (NSAIDs): inhibition of cyclooxygenase and induction of NSAID-activated gene. J. Pharmacol. Exp. Ther. 301, 1126-1131.
4. Bagavandoss P. (1998). Differential distribution of gelatinases and tissue inhibitor of metalloproteinase-1 in the rat ovary. J. Endocrinol. 158, 221-228.
5. Bauminger S. and Lindner H.R. (1975). Periovulatory changes in ovarian prostaglandin formation and their hormonal control in tue rats. Prostaglandins 9, 737-751.
6. Bjersing L. and Cajander S. (1975). Ovulation and the role of the ovarian surface epithelium. Experientia 31, 605-608.
7. Brännström M. and Janson P.O. (1991). The biochemistry of ovulation. In: Ovarian endocrinology. Hillier S.G. (ed). Blackwell Scientific Publications. Oxford. pp 132-166.
8. Brown C.G. and Poyser N.L. (1984). Studies on ovarian prostaglandins production in relation to ovulation in the rat. J. Reprod. Fert. 72, 404-414.
9. Butler T.A., Zhu C., Mueller R.A., Fuller G.C., Lemaire W.J. and Woessner J.F. Jr. (1991). Inhibition of ovulation in the perfused rat ovary by the synthetic collagenase inhibitor SC 44463. Biol. Reprod. 44, 1183-1188.
10. Carrette O., Nemade R.V., Day A.J., Brikner A. and Larsen W.J. (2001). TSG-6 is concentrated in the extracellular matrix of mouse cumulus oocyte complexes through hyaluronan and inter-alpha-inhibitor binding. Biol. Reprod. 65, 301-308.
11. Chun S.Y., Popliker M., Reich R. and Tsafriri A. (1992). Localization of preovulatory expression of plasminogen activator inhibitor type-1 and tissue inhibitor of metalloproteinase type-1 mRNAs in the rat ovary. Biol. Reprod. 47, 245-253
12. Cryer B. and Dubois A. (1998). The advent of highly selective inhibitors of cyclooxygenase- a review. Prostagland. & Other Lipid Mediat. 56, 341-361.
13. Curry T.E. Jr., Clark M.R., Dean D.D., Woessner J.F. Jr. and LeMarie W.J.J. (1986). The preovulatory increase in ovarian collagenase activity in the rat is independent of prostaglandin production. Endocrinology 11, 1823-1828.
14. Curry T.E. Jr. and Osteen K.G. (2001). Cyclic changes in the matrix metalloproteinase system in the ovary and uterus Biol. Reprod. 64, 1285-1296.
15. Curry T.E. Jr., Song L. and Wheeler S.E. (2001). Cellular localization of gelatinases and tisssue inhibitors of metalloproteinases during follicular growth, ovulation, and early luteal formation in the rat. Biol Reprod. 65, 855-865.
16. Davis B.J., Lennard D.E., Lee C.A., Tiano H.F., Morham S.G., Wetsel W.C. and Langenbach R. (1999). Anovulation in cyclooxygenase-2 deficient mice is restored by prostaglandin E2 and interleukin-1â. Endocrinology 140, 2685-2695.
17. De Silva M. and Reeves J.J. (1985). Indomethacin inhibition of ovulation in the cow. J. Reprod. Fertil. 75, 547-549.
18. Downs S.M. and Longo F.J. (1982). Effects of indomethacin on preovulatory follicle in immature, superovulated mice. Am. J. Anat. 164, 265-274.
19. Downs S.M. and Longo F.J. (1983). An ultrastructural study of preovulatory apical development in mouse ovarian follicles: effects of indomethacin. Anat. Rec. 205, 159-168.
20. Duffy D.M. and Stouffer R.L. (2002). Follicular administration of a cyclooxygenase inhibitor can prevent oocyte release without alteration of normal luteal function in rhesus monkeys. Humam Reprod. 17, 2825-2831.
21. Epigg J.J. (1981). Prostaglandin E2 stimulates cumulus expansion and hyaluronic acid synthesis by cumuli oophori isolated from mice. Biol. Reprod. 25, 191-195.
22. Espey L.L (1967). Ultrastructure of the apex or the rabbit Graafiam follicle ovulation during the ovulatory proccess. Endocrinology 81. 267-276.
23. Espey L.L. (1980). Ovulation as an inflammatory reaction - a hypothesis. Biol. Reprod. 22, 73-106.
24. Espey L.L. and Lipner H. (1994). Ovulation. In: Physiology of reproduction. 2nd ed. Knobil E. and Neill J.D. (eds). Raven Press. New York. pp 725-780.
25. Espey L.L. and Richards J.S. (2002). Temporal and spatial patterns of ovarian gene transcription following an ovulatory dose of gonadotropin in the rat. Biol. Reprod. 67, 1662-1670.
26. Espey L.L., Coons P.J., Marsh J.M. and LeMarie W.J. (1981). Effect of indomethacin on preovulatory changes in the ultrastructure of rabbit graafian follicles. Endocrinology 108, 1040-1048.
27. Espey L.L., Norris C. and Saphire D. (1986). Effect of time and dose of indomethacin on follicular prostaglandins and ovulation in the rabbit. Endocrinology 119, 746-754.
28. Espey L.L., Tanaka N., Stacy S. and Okamura H. (1992). Inhibition of ovulation in the gonadotropin-primed immature rats by exogenous prostaqglandin E2. Prostaglandins 43, 67-74.
29. Espey L.L., Yoshioka S., Russel D., Ujioka T., Vladu B., Skelsey M., Fujii S., Okamura H. and Richards J.S. (2000). Characterization of ovarian carbonyl reductase gene expression during ovulation in the gonadotropin-primed immature rat. Biol. Reprod. 62, 390-397.
30. Gaytán F., Tarradas E., Bellido C., Morales C. and Sánchez-Criado J.E. (2002a). Prostaglandin E1 inhibits abnormal follicle rupture and restores ovulation in indomethacin-treated rats. Biol. Reprod. 67, 1140-1147.
31. Gaytán F., Tarradas E., Morales C., Bellido C. and Sánchez-Criado J.E. (2002b). Morphological evidence for uncontrolled proteolytic activity during the ovulatory process in indomethacin-treated rats. Reproduction 123, 639-649.
32. Gaytán F., Bellido C., Gaytán M., Morales C. and Sánchez-Criado J.E. (2003). Differential effects of RU486 and indomethacin on follicle rupture during the ovulatory process in the rat. Biol. Reprod. 69, 99-105.
33. Gaytán M., Bellido C., Morales C., Gonzalez-Padilla M., Sanchez-Criado J.E. and Gaytan F. (2004). Immature rats show ovulatory deffects similar tot hose in adult rats lacking prostaglandin and progesterone actions. Reprod. Biol. Endocrinol. 2, 63-74.
34. Gilroy D.W. and Colville-Nash P.R. (2000). New insights into the role of COX-2 in inflammation. J. Mol. Med. 78, 121-129.
35. Goldman S. and Shalev E. (2004). MMPS and TIMPS in ovarian physiology and pathophysiology. Front. Biosci. 9, 2474-2483.
36. Hall J.A., Meisterling E.M., Lewis P.E. and Dailey R.A. (1989). Formation of ovarian follicular cysts and corpora lutea after treatment with antihistamine or indomethacin in prepubertal gilts. Biol. Reprod. 40, 565-569.
37. Hamada Y., Bronson R.A., Wright K.H. and Wallach E.E. (1977). Ovulation in the perfused rabbit ovary: the influence of Prostaglandins and prostaglandin inhibitors. Biol. Reprod. 17, 58-63.
38. Hedin L., Gaddy-Kurten G., Kurten R., Dewitt W. and Richards J. (1987). Prostaglandin endoperoxide synthase in rat ovarian follicles: content, cellular distribution and evidence for hormonal induction preceding ovulation. Endocrinology 121, 722-731.
39. Herschman H.R. (1996). Prostaglandin synthase 2. Biochim. Biophys. Acta 1299, 125-140.
40. Hibbert M.L., Stouffer R.L., Wolf D.P. and Zelinski-Wooten M.B. (1996). Midcycle administration of a progesterone synthesis inhibitor prevents ovulation in primates. Proc. Natl. Acad. Sci. USA 93, 1897-1901.
41. Hizaki H., Segi E., Sugimoto Y., Hirose M., Saji T., Ushikubi F., Matsuoka T., Noda Y., Tanaka T., Yoshida N., Narumiya S. and Ichikawa A. (1999). Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP2. Proc. Natl. Acad. Sci. USA 96, 10501-10506.
42. Holmes P.V., Janson P.O., Sogn J., Källfelt B., LeMarie W.J., Ahrén K.B., Cajander S. and Bjersing L. (1983). Effects of prostaglandin-F2a and indomethacin on ovulation and steroid production in the isolated perfused rabbit ovary. Acta Endocrinol. 104, 233-239.
43. Joyce I.M., Pendola F.L., O'Brien R. and Epigg J.J. (2001). Regulation of prostaglandin endoperoxide synthase 2 messenger ribonucleic acid expression in mouse granuloma cells during ovulation. Endocrinology 142, 3187-3197.
44. Kang H.J., Song M.J., Choung M.Y., Kim S.J. and Le M.O. (2000). Transcriptional induction of Nurr77 by indomethacin taht results in apoptosis of colon cancer cells. Biol. Pharm. Bull. 23, 815-819.
45. Killick S. and Elstein M. (1987). Pharmacologic production of luteinized unruptured follicles by prostaglandin synthetase inhibitors. Fertil. Steril. 47, 773-777.
46. Komar C.M., Braissant O., Wahli W. and Curry Jr. T.E. (2001). Expression and localization of PPARs in the rat ovary during follicular development and the periovulatory period. Endocrinology 142, 4831-4838.
47. Lim H., Paria B.C., Das S.K., Dinchuck J.E., Langenbach R., Trzaskos J.M. and Dey S.K. (1997). Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 91, 197-208.
48. Liu K., Wahlberg P. and Ny T. (1998). Coordinated and cell-specific regulation of membrane type matrix metalloproteinase 1 (MT1-MMP) and its substrate matriz metalloproteinase 2 (MMP-2) by physiological signals during follicular development and ovulation Endocrinology 139, 4735-4738.
49. Lydon J.P., DeMayo F.J., Conneely O.M. and O'Malley B.W. (1996). Reproductive phenotypes of the progesterone receptor null mutant mouse. J. Steroid. Biochem. Mol. Biol. 56, 66-77.
50. Mann J.S., Kindy M.S., Hyde J.F., Clark M.R. and Curry T.E. Jr. (1993). Role of protein synthesis, prostaglandins, and estrogen in rat ovarian metalloproteinase inhibitor production. Biol. Reprod. 48, 1006-1013.
51. Matsumoto H., Ma W., Smalley W., Trzaskos J., Breyer R.M. and Dey S.K. (2000). Diversification of cyclooxygenase-2-derived Prostaglandins in ovulation and implantation. Biol. Reprod. 64, 1557-1565.
52. Mendonça L.L.F., Khamashta M.A., Nelson-Piercy C., Hunt B.J. and Hughes G.R.V. (2000). Non-steroidal anti-inflammatory drugs as a possible cause for reversible infertility. Rheumatology 39, 880-882.
53. Mikuni M., Pall M., Peterson C.M., Peterson C.A., Hellberg P., Brännström M., Richards J.S. and Hedin L. (1998). The selective prostaglandin endoperoxide synthase-2 inhibitor, NS-398, reduces prostaglandin production and ovulation in vivo and in vitro in the rat. Biol. Reprod. 59, 1077-1083.
54. Mori T., Suzuku A., Nishimura T. and Kambegawa A. (1977). Inhibition of ovulation in immature rats by antiprogesterone antiserum. J. Endocrinol. 73, 185-186.
55. Murdoch W.J. and Cavender J.L. (1989). Effect of indomethacin of the vascular architecture of preovulatory ovine follicles: possible implication in the luteinized unruptured of follicle syndrome. Fertil. Steril. 51, 153-155.
56. Murdoch W.J. and McCormick R.J. (1991). Dose-dependent effects of indomethacin on ovulation in the sheep: relationship to follicular prostaglandin production, steroidogenesis, collagenolysis, and leukocyte chemotaxis. Biol. Reprod. 45, 907-911.
57. Murdoch W.J., and McDonnel A.C. (2002). Roles of the ovarian surface epithelium in ovulation and carcinogenesis. Reproduction 123, 743-750.
58. Murdoch W.J. and Myers D.A. (1983). Effects of treatment of estrous ewes with indomethacin on the distribution of ovarian blood to the periovulatory follicle. Biol. Reprod. 29, 1229-1232.
59. Murdoch W.J., Peterson P.A., van Kirk E.A,. Vicent D.L. and Inskeeo E.K. (1986). Interactive roles of progesterone, prostaglandins, and collagenase in the ovulatory mechanism of the ewe. Biol. Reprod. 35, 1187-1194.
60. Natraj U. and Richards J. (1993). Hormonal regulation, localization, and functional activity of the progesterone receptor in granuloma cells of rat preovulatory follicles. Endocrinology 133, 761-769.
61. Norman R.J. (2001). Reproductive consequences of COX-2 inhibition. Lancet 358, 1287-1288.
62. Norman R.J. and Wu R. (2004). The potential danger of COX-2 inhibitors. Fertil. Steril. 81, 493-494.
63. Ny T., Wahlberg P. and Brändström I.J.M. (2002). Matrix remodeling in the ovary: regulation and functional role of the plasminogen activator and matrix metalloproteinase systems. Mol. Cell. Endocrinol. 187, 29-38.
64. Ochsner S.A., Russell D.L. and Richards J.S. (2003). Decreased expression of tumor necrosis factor-α-stimulated gene 6 in cumulus cells of the cyclooxygenase-2 and EP2 null mice. Endocrinology 144, 1008-1019.
65. Osman P. and Dullaart J. (1976). Intraovarian release of eggs in the rat after indomethacin treatment at pro-oestrus. J. Reprod. Fertil. 47, 101-103.
66. Pall M., Friden B.E. and Brannstrom M. (2001). Induction of delayed follicular rupture in the human by the selective COX-2 inhibitor rofecoxib: a ramdomized double-blind study. Hum. Reprod. 16, 1323-1328.
67. Park O.K. and Mayo K.E. (1991). Transient expression of progesterone receptor messenger RNA in ovarian granuloma cells after the preovulatory luteinizing hormone surge. Mol. Endocrinol. 5, 967-978.
68. Parr E.L. (1974). Histological examination of the rat ovarian follicle wall prior to ovulation. Biol. Reprod. 11, 483-503.
69. Rawson J.M. and Espey L.L. (1977). Concentration of electron dense granules in the rabbit. Biol. Reprod. 17, 561-566.
70. Reese J., Paria B.C., Brown N., Zhao X., Morrow J.D. and Dey S.K. (2000). Coordinated regulation of fetal and maternal prostaglandins directs successful birth and postnatal adaptation in the mouse. Proc. Natl. Acad. Sci. USA 97, 9759-9764.
71. Reese J., Zhao X., Ma W., Brown N., Maziasz T.J. and Dey S.K. (2001). Comparative analysis of pharmacologic and/or genetic disruption of cyclooxygenase-1 and cyclooxygenase-2 function in female reproduction in mice. Endocrinology 142, 3198-3206.
72. Reich R., Tsafriri A. and Mechanic G.L. (1985). The involvement of collagenolysis in ovulation in the rat. Endocrinology 116, 522-527.
73. Reich R., Daphna-Iken D., Chun S.Y., Popliker M., Slager R., Adelmann-Grill B.C. and Tsafriri A. (1991). Preovulatory changes in ovarian expression of collagenases and tissue metalloproteinase inhibitor messenger ribonucleic acid:role of eisosanoids. Endocrinology 129, 1869-1875.
74. Richards J.S. (2005). Ovulation: new factors that prepare the oocyte for fertilization. Mol. Cell. Endocrinol. 234, 75-79.
75. Richards J.S., Russell D.L., Ochsner S., Hsieh M., Doyle K.H., Falender A.E., Lo Y.K. and Sharma S.C. (2002) Novel signaling pathways that control ovarian follicular development, ovulation, and luteinization. Recent. Prog. Horm. Res. 57, 195-220.
76. Robker R.L., Russell D.L., Espey L.L., Lydon J.P., O'Malley B.W. and Richards J.S. (2000a). Progesterone-regulated genes in ovulation process: ADAMTS-1 and cathepsin-L proteases. Proc. Natl. Acad. Sci. USA 97, 4689-4694.
77. Robker R.L., Russell D.L., Yoshioka S., Sharma S.C., Lydon J.P., O'Malley B.W., Espey L.L. and Richards J.S. (2000b). Ovulation: a multi-gene, multi-step process. Steroids 65, 559-570.
78. Rodbard D. (1968). Mechanics of ovulation. J. Clin. Endocrinol. Metab. 28, 849-861.
79. Rose U.M., Hanssen R.G.J.M. and Kloosterboer H.J. (1999). Development and characterization of an in vitro ovulation model using mouse ovarian follicles. Biol. Reprod. 61, 503-511.
80. Russell D.L. and Richards J.S. (1997). Causes of infertility in mice with targeted deletion of the PGS-2 gene Biol. Reprod. Supp. 56, 178 (abstract 382).
81. Sánchez-Criado J.E., Bellido C., Galiot F., López F.J. and Gaytán F. (1990). A posible dual mechanism of the anovulatory action of antiprogesterone RU486 in the rat. Biol. Reprod. 42, 877-886.
82. Schmidt G., Holmes P.V., Owman CH., Sjöberg N.O. and Wailes B. (1986). The influence of prostaglandin E2 and indomethacin on progesterone production and ovulation in the rabbit ovary perfused in vitro. Biol. Reprod. 35, 815-821.
83. Simpson K.S., Byers M.J. and Curry T.E. Jr. (2001). Spatiotemporal messenger ribonucleic acid expression of ovarian tissue inhibitors of metalloproteinases throughout the rat estrous cycle. Endocrinology 142, 2058-2069.
84. Sirois J., Simmons D.L. and Richards J. (1992). Hormonal regulation of messenger ribonucleic acid of prostaglandin endoperoxide synthase in rat preovulatory follicles. J. Biol. Chem. 267, 11586-11592.
85. Sirois J. and Dore M. (1997). The late induction of prostaglandin G/H synthetase-2 in equine preovulatory follicle supports its role as determinat of the ovulatory process. Endocrinology 138, 4427-4434.
86. Smith W.L., Garavito R.M. and DeWitt D.L. (1996). Prostaglandin endoperoxide H synthetases (cyclooxygenases)-1 and 2. J. Biol. Chem. 271, 33157-33160.
87. Snyder B., Beecham G. and Schane H. (1984). Inhibition of ovulation in rats with epostane, an inhibitor of 3β-hydroxysteroid dehydrogenase. Proc. Soc. Exp. Biol. Med. 176, 238-242.
88. Sogn J.H., Curry T.E. Jr., Brännström M., LeMaire W.J., Koos R.D., Papkoff H. and Janson P.O. (1987). Inhibition of follicle-stimulating hormone-induced ovulation by indomethacin in the perfused rat ovary. Biol. Reprod. 36, 536-542.
89. Stone S., Khamshta M.A. and Nelson-Piercy C. (2002). Non-steroidal anti-inflammatory drugs and reversible female infertility: is there a link?. Drug Saf. 25, 545-551.
90. Tanaka N., Espey L.L., Stacy S. and Okamura H. (1992). Epostane and indomethacin actions on ovarian kallikrein and plasminogen activator activities during ovulation in the gonadotropin-primed immature rats. Biol. Reprod. 46, 665-670.
91. Tegeder I., Pfeilschifter J. and Geisslinger G. (2001). Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J. 15, 2057-2072.
92. Tsafriri A. and Reich R (1991). Plasminogen activators in the preovulatory follicle role in ovulation. In: Plasminogen activators from cloning to therapy. Abbate R., Barni T. and Tsafriri A. (eds), Raven Press. New York. pp 81-93.
93. Tsafriri A., Chun S.Y. and Reich R. (1993). Follicular rupture and ovulation. In: The ovary. Adashi E.Y. and Leung P.C.K (eds). Raven Press. New York. pp 228-243.
94. Van der Schoot P., Bakker G.H. and Kljin J.G. (1987). Effects of the progesterone antagonist RU486 on ovarian activity in the rat. Endocrinology 121, 1375-1382.
95. Vane J.R., Bakhle Y.S. and Botting R.M. (1998). Cyclooxygenase 1 and 2. Annu. Rev. Pharmacol. Toxicol. 38, 97-120.
96. Wallach E.E., Bronson R., Hamada Y., Wright K.H. and Stevens V.C. (1975a). The effectiveness of prostaglandin F2a in restoration of HMG-HCG induced ovulation in indomethacin-treated rhesus monkeys. Prostaglandins 10, 129-138.
97. Wallach E.E., de la Cruz A., Hunt J., Hamada Y., Wright K.H. and Stevens V.C. (1975b). The effect of indomethacin on HMG-HCG induced ovulation in the rhesus monkey. Prostaglandin 9, 645-658.
98. Zaragnolo V., Dharmarajan A.M., Endo K. and Wallach E.E. (1996). Effects of acetylsalicylic acid (aspirin) and naproxen sodium (naproxen) on ovulation, prostaglandin, and progesterone production in the rabbit. Fert. Steril. 65, 1036-1043.